Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2
NCT ID: NCT01771601
Last Updated: 2013-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2013-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters
NCT01665287
Cerebral Tissue Oxygenation Values in Newborns Measured Using Laser and LED NIRS Oximeters
NCT01496027
OxyPrem Validation Study
NCT04860401
Pulse Oximetry Performance Comparison in Newborns
NCT06637917
Validation of Fore-Sight Cerebral & Tissue Oximeter Saturation Measurements on Neonates ≤ 5 kg
NCT02017652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Near-infrared spectroscopy sensors
Term infants born by elective Caesarean section
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective caesarean section
Exclusion Criteria
* obvious malformations or syndromes
* Complications in relation to caesarean section
* Depression after birth (APGAR \< 8 after 1 minute)
10 Minutes
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Augustinus Foundation, Denmark.
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gorm Greisen
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gorm Greisen
Copenhagen, Copenhagen, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
090113OXYVOS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.